Study of COLAL-PRED® in the treatment of moderate acute ulcerative colitis
Not Applicable
Completed
- Conditions
- Moderate acute ulcerative colitisDigestive System
- Registration Number
- ISRCTN71669877
- Lead Sponsor
- Alizyme (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 750
Inclusion Criteria
1. Endoscopically confirmed diagnosis of ulcerative colitis
2. Score of 6-10 on the disease activity index (DAI)
3. Moderate to severe mucosal appearance
Exclusion Criteria
1. Previous colonic surgery
2. Other treatments for ulcerative colitis that have not been stabilised
3. Clinically significant diabetes
4. Heart failure
5. Unstable angina
6. Cirrhosis
7. Renal failure
8. History of tuberculosis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method